-The Times of India NEW DELHI: Within days of Prime Minister Narendra Modi's return from the US, the US Trade Representative (USTR) has launched a fresh offensive against India's intellectual property rights (IPR) regime, a move that may lead to the government going slow on a bilateral dialogue with Washington. On Tuesday, USTR will launch what it calls an "out-of-cycle review" (OCR) of India's IPR regime, following a report released earlier this...
More »SEARCH RESULT
Total Matching Records found : 977
Fighting India’s silent epidemic -Soumya Swaminathan and Chapal Mehra
-The Hindu Tackling TB requires both strengthening the public sector and engaging the private sector Over 60 per cent of all Indians seek health care in the private sector according to India's last National Family Health Survey. This undoubtedly makes the private sector the largest provider of health services in India. The government health system, though vast and well-intentioned, continues to be overburdened with multiple challenges including long waiting hours, an ageing...
More »SC agrees on urgent hearing of drug price plea
-The Telegraph The Supreme Court today agreed to take up "as early as possible" a plea challenging a recent NDA government decision that is alleged to have paved the way for a sharp rise in the prices of life-saving Drugs. Petitioner Manohar Lal Sharma, a lawyer, has demanded a CBI probe into a September 22 government order that he says frees a list of medicines from pricing control. His public interest plea alleges...
More »Why did PM Modi agree to give away India’s patent sovereignty to Americans? -G Pramod Kumar
-FirstPost.com With the hype of his Madison Square Garden show overshadowing everything else, Prime Minister Narendra Modi's US visit was dubbed as a great bilateral victory for India. As the popular consensus went, Modi wowed both the Indian Americans and American politicians and even managed to get a joint op-ed article with President Barack Obama in the Washington Post stressing the importance of the partnership between the two countries. Was it really...
More »Cancer drug price goes up from Rs 8,000 to Rs 1.08 lakh -Iftikhar Gilani
-DNA The Union government decision to decontrol prices of 108 Drugs -- used to treat tuberculosis, AIDS, diabetes and heart ailments -- has jacked up their prices. In some cases, prices have seen an unbelievable rise. The price of Glivec, an anti-cancer tablet, for example, has risen from Rs 8,500 to Rs 1.08 lakh. Plavix, used to treat blood pressure and heart ailments, will cost Rs 1,615, against the earlier Rs 147. An...
More »
